Jacob D. Cohen insider trades
Open-market stock purchases and sales by Jacob D. Cohen, Chief Executive Officer at Mangoceuticals, Inc, from SEC Form 4 filings since May 20, 2020.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -64%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 16, 2026 | MGRX Mangoceuticals, Inc | Sold (not open market) | — |
| Mar 16, 2026 | MGRX Mangoceuticals, Inc | Bought (not open market) | — |
| Mar 16, 2026 | MGRX Mangoceuticals, Inc | Sold (not open market) | — |
| Mar 16, 2026 | MGRX Mangoceuticals, Inc | Bought (not open market) | — |
| Mar 16, 2026 | MGRX Mangoceuticals, Inc | Sold (not open market) | — |
| Mar 16, 2026 | MGRX Mangoceuticals, Inc | Bought (not open market) | — |